Biomarkers in systemic lupus erythematosus: II. Markers of disease activity
- 6 July 2004
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (7) , 2048-2065
- https://doi.org/10.1002/art.20345
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- Clinical Utility of Selected Disease Activity Markers in Patients with Systemic Lupus ErythematosusClinical Rheumatology, 2001
- Increased Level of Soluble HLA Class I Antigens in Systemic Lupus Erythematosus: Correlation with Anti-DNA Antibodies and LeukopeniaJournal of Autoimmunity, 2001
- Temperature renormalization of the magnetic excitations in S = 1/2 KCuCl3Zeitschrift für Physik B Condensed Matter, 2000
- Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α Levels and Disease Acitivity in Systemic Lupus ErythematosusClinical Rheumatology, 1999
- Elevated Soluble CD27 Levels in Serum of Patients with Systemic Lupus ErythematosusClinical Immunology and Immunopathology, 1996
- The Value of Complement Activation Products in the Assessment of Systemic Lupus Erythematosus FlaresClinical Immunology and Immunopathology, 1995
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunityClinical Immunology and Immunopathology, 1990
- Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseasesClinical Immunology and Immunopathology, 1989
- Changes in the activity and isozyme patterns of glycolytic enzymes during stimulation of normal human lymphocytes with phytohaemagglutininAnnals of Human Genetics, 1980